Oncolytics Biotech SEC Filing Effectiveness
Ticker: ONCY · Form: EFFECT · Filed: Apr 6, 2026 · CIK: 0001129928
Sentiment: neutral
Topics: registration-statement, effectiveness, sec-filing
TL;DR
ONCO registration statement effective 4/6/26. Big step for them.
AI Summary
Oncolytics Biotech Inc. filed an EFFECT form on April 6, 2026, indicating the effectiveness of a registration statement. The filing relates to Act 33 and has the file number 333-294811. The company's mailing and business address is Suite 325, 4350 Executive Drive, San Diego, CA 92121.
Why It Matters
This filing signifies that a registration statement for Oncolytics Biotech Inc. has been declared effective by the SEC, which is a crucial step for certain securities offerings or transactions.
Risk Assessment
Risk Level: low — This is a procedural filing indicating the effectiveness of a registration statement, not a filing detailing significant financial changes or events.
Key Numbers
- 2026-04-06 — Filing Date (Date the EFFECT filing was accepted by the SEC.)
- 2026-04-03 — Effectiveness Date (The date the registration statement became effective.)
Key Players & Entities
- Oncolytics Biotech Inc. (company) — Filer
- 9999999995-26-001090 (dollar_amount) — SEC Accession Number
- 2026-04-06 (dollar_amount) — Filing Acceptance Date
- 2026-04-03 (dollar_amount) — Effectiveness Date
- 333-294811 (dollar_amount) — File Number
FAQ
What type of registration statement became effective?
The filing does not specify the exact type of registration statement, only that it is an 'EFFECT' filing indicating its effectiveness.
What is the CIK number for Oncolytics Biotech Inc.?
The CIK number for Oncolytics Biotech Inc. is 0001129928.
What is the company's state of incorporation?
Oncolytics Biotech Inc. is incorporated in Nevada (NV).
What is the SIC code for Oncolytics Biotech Inc.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the SEC accession number for this filing?
The SEC accession number for this filing is 9999999995-26-001090.
Filing Stats: 33 words · 1 min read · ~1 pages · Grade level 10.2 · Accepted 2026-04-06 00:15:22
Filing Documents
- primary_doc.html (EFFECT)
- primary_doc.xml (EFFECT) — 1KB
- 9999999995-26-001090.txt ( ) — 2KB
From the Filing
Notice of Effectiveness UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Notice of Effectiveness Effectiveness Date: April 3, 2026 4:30 P.M. Form: S-3 CIK: Company Name: ONCOLYTICS BIOTECH INC File Number: 333-294811